Rare disease, twin girl with Dopa Responsive Dystonia suspicious Segawa disease in Indonesia
Keywords:
dopa-responsive dystonia, segawa disease, DRD, levodopaAbstract
.
References
Nygaard G, Szigetvari PD, Grindheim AK, et al. Personalized Medicine to Improve Treatment of Dopa-Responsive Dystonia-A Focus on Tyrosine Hydroxylase Deficiency. J Pers Med. 2021 Nov 12;11(11):1186. doi: 10.3390/jpm11111186.
Lee WW, Jeon B, Kim R. Expanding the Spectrum of Dopa-Responsive Dystonia (DRD) and Proposal for New Definition: DRD, DRD-plus, and DRD Look-alike. J Korean Med Sci. 2018 May 24;33(28):e184. doi: 10.3346/jkms.2018.33.e184.
Gorodetsky C, Fasano A. Approach to the Treatment of Pediatric Dystonia. Dystonia. 2022;1:10287. doi: 10.3389/dyst.2022.10287.
Segawa M. Hereditary Progressive Dystonia with Marked Diurnal Fluctuation. Brain Dev. 2011;33:195–201. doi: 10.1016/j.braindev.2010.10.015.
Gunawan PI, Saharso D. Reducing Severe Spasticity in Cerebral Palsy Following Meningoencephalitis by Botulinum Toxin. Med J Indones. 2017;26:1. doi: 10.13181/mji.v26i1.1297.
Downloads
How to Cite
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.